The best indicator for Amgen (AMGN)
We backtested 366 indicators across daily, weekly and hourly charts on real Amgen (AMGN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMC: Change of Character
On the weekly chart, this is the strongest risk-adjusted edge we found for Amgen (AMGN) over ~43.1 years — trailing buy-and-hold by 1.6% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Amgen (AMGN) — trailing buy-and-hold by 11.6% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMC: Change of Character ✓ | Weekly | 16.9% | 0.68 | -62.0% | 58.3% | 24 | -1.6% |
| 2 | Markov Regime ✓ | Weekly | 17.4% | 0.68 | -65.8% | 55.0% | 120 | -1.1% |
| 3 | Zero-Lag LSMA ✓ | Weekly | 14.2% | 0.65 | -58.5% | 55.9% | 145 | -4.3% |
| 4 | QQE ✓ | Weekly | 17.8% | 0.65 | -56.4% | 49.6% | 133 | -0.7% |
| 5 | HMA 9/21 Cross ✓ | Weekly | 14.3% | 0.64 | -56.9% | 55.6% | 144 | -4.2% |
| 6 | Trend Intensity Index ✓ | Weekly | 15.8% | 0.63 | -61.0% | 73.3% | 15 | -2.7% |
| 7 | T3 10/40 Cross ✓ | Daily | 13.8% | 0.62 | -53.8% | 53.3% | 137 | -4.7% |
| 8 | Net Volume ✓ | Weekly | 15.1% | 0.62 | -61.5% | 50.0% | 110 | -3.4% |
| 9 | Liquidity Flow Oscillator ✓ | Weekly | 15.1% | 0.62 | -61.5% | 50.0% | 110 | -3.4% |
| 10 | Intraday Momentum Index ✓ | Daily | 12.9% | 0.61 | -59.2% | 77.1% | 118 | -5.7% |
| 11 | VIDYA 100 Trend ✓ | Daily | 15.7% | 0.61 | -70.1% | 34.8% | 66 | -2.9% |
| 12 | SMA 15/60 Cross ✓ | Weekly | 15.3% | 0.61 | -69.3% | 52.4% | 21 | -3.2% |
| 13 | SMA 20/80 Cross ✓ | Weekly | 15.2% | 0.61 | -57.7% | 61.1% | 18 | -3.3% |
| 14 | SMC: Break of Structure ✓ | Weekly | 14.8% | 0.61 | -62.9% | 56.5% | 23 | -3.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Amgen (AMGN), SMC: Change of Character on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.